RxDoctor Payments Data

Jonathan Velasco, MD

Vascular Surgery · Dayton, OHNPI 1962477661

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,869 of the $2,398 with a category attached, or 78.0%. It is spread thinly across 15 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $776 and has fallen 85.1% since, to $115 in 2025. That places this record below the midpoint for vascular surgery clinicians in OH, where the typical reported total is $3,770.

$2,398in general payments, 2019–2025

Across 43 payments — averaging $55.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$477
  • Endologix LLC$340
  • Silk Road Medical, Inc.$318
  • W. L. Gore & Associates, Inc.$312
  • Abbott$174
  • Medtronic$169
  • plus $608 from 9 others
$8,732in research payments, 2019–2025

Across 15 payments — averaging $582.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endologix LLC$9K

What the payments were for

  • Travel & lodging$52822%
  • Food & beverage$1,86978%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,398 in reported general payments places this provider in the 30th percentile of 213 vascular surgery providers in Ohio.

See all vascular surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$158,370
Medicare patients
357
Services billed
667

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban31$33,449
ClopidogrelClopidogrel Bisulfate87$606
Cilostazol27$279
Gabapentin17$177
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen23$119
Tramadol Hcl14$95
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$43
Prednisone16$16
Famotidine17$10

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Dayton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →